Notice Of Thirty- Fourth (34Th) Annual General Meeting
Filed with BSE · · 201 pages · English
Summary by 6ix AI
The meeting is scheduled to be held through video conferencing, allowing shareholders to participate remotely. The notice outlines the agenda, including the adoption of financial statements, declaration of dividends, and re-appointments of directors. Additionally, it addresses the increase in authorized share capital and the approval for issuing bonus equity shares to members.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Reg. 34 (1) Annual Report.
- Titan Biotech Limited Press Release Sep 04 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Sep 03 2026
- Intimation Of Record Date For The Purpose Of Final Dividend
Later from Titan Biotech
- Titan Biotech Limited Press Release Sep 07 2026
- Titan Biotech Limited Press Release Sep 10 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Titan Biotech Limited Press Release Sep 29 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech